Quantum Biopharma (QNTM) Research & Development (2020 - 2026)
Quantum Biopharma (QNTM) posted Research & Development of $626092.0 for Q1 2026, up 789.28% sequentially from $70404.0 in Q4 2025, and down 62.02% YoY from $1.6 million in Q1 2025.
Quantum Biopharma (QNTM) Research & Development (2020 - 2026) Analysis & Trends
Quantum Biopharma (QNTM) has 7 years of Research & Development data on file, last reported at $626092.0 in Q1 2026.
- Quarterly Research & Development fell 62.02% year-over-year to $626092.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.7 million (down 49.56% YoY) and the FY2025 annual result came in at $2.8 million, down 54.58% from the prior year.
- Research & Development improved to $626092.0 in Q1 2026 per QNTM's latest filing, from $70404.0 in the prior quarter.
- The five-year high for Research & Development was $2.3 million in Q1 2023, with the low at $32985.0 in Q3 2023.
- Average Research & Development over 5 years is $719517.2, with a median of $587644.5 recorded in 2025.
- The widest YoY moves for Research & Development: up 2158.0% in 2024, down 93.07% in 2024.
- Quantum Biopharma's Research & Development stood at $937052.0 in 2022, then sank by 96.48% to $32985.0 in 2023, then surged by 385.86% to $160260.0 in 2024, then tumbled by 56.07% to $70404.0 in 2025, then surged by 789.28% to $626092.0 in 2026.
- Business Quant data shows QNTM's Research & Development at $626092.0 in Q1 2026, $70404.0 in Q4 2025, and $495223.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Genmab A | 276,399.99 Bn | 276,398.47 Bn | 831.00 Mn | -440.00 Mn |
| 2 | Akari Therapeutics | 1,217.26 Bn | 1,217.26 Bn | - | 1.46 Mn |
| 3 | BeOne Medicines | 419.38 Bn | 414.59 Bn | 1.35 Bn | 541.22 Mn |
| 4 | Vertex Pharmaceuticals | 126.54 Bn | 119.30 Bn | 2.59 Bn | 961.60 Mn |
| 5 | Pharming | 110.17 Bn | 110.12 Bn | 65.80 Mn | -25.56 Mn |
| 6 | Regeneron Pharmaceuticals | 64.97 Bn | 56.22 Bn | 3.31 Bn | 1.54 Bn |
| 7 | Argenx Se | 56.44 Bn | 56.44 Bn | 1.18 Bn | -443.00 Mn |
| 8 | Alnylam Pharmaceuticals | 40.09 Bn | 37.08 Bn | 959.66 Mn | 364.87 Mn |
| 9 | Revolution Medicines | 37.15 Bn | 37.15 Bn | - | 343.97 Mn |
| 10 | Quantum Biopharma | 15.08 Mn | 8.50 Mn | - | 626,092.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 626,092.00 |
| Dec 31, 2025 | 70,404.00 |
| Sep 30, 2025 | 495,223.00 |
| Jun 30, 2025 | 549,197.00 |
| Mar 31, 2025 | 1.65 Mn |
| Dec 31, 2024 | 160,260.00 |
| Sep 30, 2024 | 744,802.00 |
| Jun 30, 2024 | 897,986.00 |
| Mar 31, 2024 | 160,260.00 |
| Sep 30, 2023 | 32,985.00 |
| Mar 31, 2023 | 2.31 Mn |
| Mar 31, 2022 | 937,052.00 |
| Jun 30, 2021 | 3.61 Mn |
| Sep 30, 2020 | 3.50 Mn |
| Jun 30, 2020 | 1.13 Mn |
| Mar 31, 2020 | 226,299.20 |